Braveheart Bio Statistics
NASDAQ: BRVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
18.58-1.21 (-6.11%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 18.58 0.00%
Braveheart Bio by the numbers
Braveheart Bio has a market capitalization of $1.67 billion based on 90.04M shares outstanding. With trailing EPS of $-6.08, Braveheart Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.1% below its 50-day average and 28.1% below its 200-day average.
Average daily trading volume is 567.47K shares, or about $10.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BRVE valuation vs. peer median
| Metric | BRVE | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.67B | $1.82B | -8% |
| Avg. volume | 567.47K | 1.80M | -69% |
Peer median across 8 companies: BHVN, XNCR, GENB, ZBIO, XERS, SRPT, ADRX, NUVB.
Valuation
- Market cap
- $1.67B
- EPS (TTM)
- $-6.08
- Shares outstanding
- 90.04M
Price and trading
- Previous close
- 19.79
- Open
- 19.61
- Day range
- 18.47 – 19.65
- 52-week range
- 18.47 – 32.00
- Beta
- —
- Volume
- 336.95K
- Average volume
- 567.47K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 1.67B
- Forward Pe
- -9.34
- Eps
- -6.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 32.00
- Week52 Low
- 18.47
- Avg Volume
- 567.47K
- Shares Outstanding
- 90.04M
- Ma50
- 25.85
- Ma200
- 25.85
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -41.94%
- Pct From52w Low
- 0.60%